← AURORA-GLIO · GliomaSUBSYSTEM 05 / 11
GLIO-INFIL

Infiltration Field

Diffusion-reaction PDE solver for invasive margins beyond contrast.

Diffusion-reaction PDE solver for invasive margins beyond contrast.

liveAURORA-GLIOpilotalpha · open at public alpha
SubsystemGLIO-INFIL
Status live
Readinessalpha · open at public alpha
Anchored inSanai 2011 · Stummer 2006 · Bakas 2017
LicenseMIT @ public alpha
Packageaurora-glio[infil]
I · Overview

Infiltration Field, in context.

GLIO-INFIL is one of 11 subsystems that compose AURORA-GLIO. It is independently usable but shares the same patient representation, provenance log and governance layer as every other AURORA module.

Contrast enhancement is not the disease. It is one signal among several. Glioma infiltrates beyond what gadolinium will show. GLIO-INFIL is a reaction-diffusion PDE solver, calibrated against histology where available, that projects an infiltration field across the surrounding parenchyma — with uncertainty bands the surgeon can read.

05
Subsystem index
11
Module total
live
Pilot status
MIT
License @ public alpha
II · What it does

A longer look.

It is conservative by design. The field is one input among several to the surgical and radiotherapy plans, not a contour to follow blindly. The point is to make the question — 'what about here?' — answerable in a way that today it usually is not.

III · Install

Install just this subsystem.

GLIO-INFIL can be installed standalone, or pulled in as part of the full AURORA-GLIO stack. Both ship the same code and weights, signed end-to-end. Pilot partners have access today; public alpha opens Q4 2026.

~ / aurora · glio-infil$ copy
pip install aurora-glio[infil]
aurora glio.infil solve \
  --case case.aurora \
  --t 30d --backend cuda
Package
aurora-glio[infil]
Hardware
CPU · NVIDIA · Apple silicon
Deploys
Cloud · On-prem · Air-gapped
Signed
Sigstore · sha256 pinned

Eight diseases is the beginning.

AURORA is in private pilot today and opens to the world at public alpha in Q4 2026 under MIT. If you carry the weight of these diseases — as a clinician, scientist, builder, patient or advocate — there is a seat at the table.